TB-500 (Thymosin Beta-4)

TB-500 is a synthetic peptide related to the natural protein Thymosin Beta-4, studied mainly in animals for repair and wound healing. In Australia it is unapproved, prescription-only/compounded, and banned in sport.

What it is

TB-500 is a synthetic peptide marketed as a version of Thymosin Beta-4 (Tβ4), a protein that occurs naturally in the body and plays a role in cell movement and tissue repair. Importantly, most products sold as "TB-500" are not the full natural protein — they are a short synthetic fragment made in a lab. It is typically supplied as a powder for reconstitution and injection. Like BPC-157, it is an experimental research compound rather than an approved medicine, and it is frequently discussed alongside BPC-157 for recovery.

How it works

Natural Thymosin Beta-4's best-understood job is binding actin, a protein involved in cell structure and movement — relevant to how cells migrate into a wound to repair it. The proposed mechanisms for TB-500 include supporting cell migration, encouraging new blood-vessel formation (angiogenesis), and reducing inflammation and scar-tissue formation. As with BPC-157, these mechanisms are drawn from laboratory and animal studies, not from confirmed effects of injected TB-500 in humans at the doses people use.

What the evidence says

The preclinical evidence base is genuine: animal and lab studies on Thymosin Beta-4 cover dermal wound healing, corneal injury, cardiac tissue repair, and tendon/ligament models, with reasonably consistent repair-promoting findings. The parent protein has also been studied in early-stage human trials for specific uses such as wound healing and dry eye. However, there is no published randomised controlled trial showing that the injected TB-500 fragment works for the muscle, tendon or general "recovery" uses it is most often marketed for. Those claims are extrapolated from animal data, not validated in humans. There is also no established safe human dose and no long-term human safety data.

Legal & regulatory status in Australia

TB-500 / Thymosin Beta-4 is not on the ARTG and is not approved by the TGA for human use. It is treated as a prescription-only (Schedule 4) substance, accessible only via a doctor and a compounding pharmacy if at all, and cannot be lawfully sold over the counter. The TGA has flagged concerns about unapproved peptides sold online. In sport, Thymosin Beta-4 and its derivatives (including TB-500) are prohibited at all times by WADA, and Sport Integrity Australia confirms it is banned and not approved for human use.

Risks & considerations

With minimal human data, TB-500's risk profile is largely unknown rather than demonstrated to be safe. Concerns mirror other research peptides: uncertain product quality, purity and labelling; infection or reactions from self-injection; unknown interactions with conditions and medications; and a theoretical concern that a compound promoting blood-vessel growth and cell migration could be unwise for anyone with, or at risk of, abnormal tissue growth. For athletes at any level, use is a clear anti-doping violation.

What to ask a doctor

• Is there a proven, approved treatment for my injury I should consider before anything experimental?
• What are the specific risks of an unapproved, largely untested peptide for someone with my health history?
• How does using this affect my anti-doping status if I compete?
• What does the absence of ARTG approval mean for product quality and my legal standing?
• Could this interact with my current medications or conditions?

FAQ

Q: Is TB-500 the same as natural Thymosin Beta-4? A: Not exactly. Most "TB-500" products are a short synthetic fragment of the natural protein, not the full molecule. Q: Is it approved or proven in humans? A: No. It is unapproved in Australia, and its popular recovery uses are based on animal/lab data, not robust human trials. Q: Can athletes use it? A: No. Thymosin Beta-4 and its derivatives, including TB-500, are prohibited at all times under WADA rules.